Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Tented upper lip vermilion, Feeding difficulties, Low muscle tone (hypotonia), and Ptosis and others. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 3 | Low muscle tone (hypotonia), Muscle weakness, Proximal muscle weakness |
PREPL function has not been fully characterized.
Myasthenic syndrome, congenital, 22 is associated with mutations in the PREPL gene on chromosome 2.
Genetic testing for PREPL is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for myasthenic syndrome, congenital, 22 has been reported in the published literature.
Phenotype severity distribution: 6 always present features.
No clinical trials have been registered for myasthenic syndrome, congenital, 22.
13 publications have been identified in PubMed for myasthenic syndrome, congenital, 22. Research spans Epidemiology / Natural History (46%), Case Report / Case Series (23%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 6 | 46% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 2:25 PM UTC
Online Mendelian Inheritance in Man
2 |
Short stature, Decreased response to growth hormone stimulation test |
Head and neck | 1 | Tented upper lip vermilion |
Digestive system | 1 | Feeding difficulties |
Lab test results | 1 | Anti-neuromuscular Junction acetylcholine receptor antibody positivity |
Eyes | 1 | Ptosis |
Hormones | 1 | Decreased response to growth hormone stimulation test |
Brain and nerves | 1 | Waddling gait |
Patient case studies
3 |
23% |
Testing and diagnosis research | 2 | 15% |
Laboratory research | 2 | 15% |
Wang T (2026). [PMID: 41547082](https://pubmed.ncbi.nlm.nih.gov/41547082/). *Pediatric neurology*. [Epidemiology / Natural History]
Akçay AA (2026). [PMID: 41451794](https://pubmed.ncbi.nlm.nih.gov/41451794/). *Clinical genetics*. [Epidemiology / Natural History]
Erturk AY (2026). [PMID: 41517821](https://pubmed.ncbi.nlm.nih.gov/41517821/). *Journal of clinical neurology (Seoul, Korea)*. [Case Report / Case Series]
Ivanovic V (2026). [PMID: 41940306](https://pubmed.ncbi.nlm.nih.gov/41940306/). *Frontiers in neurology*. [Diagnostic / Biomarker]
Ramjattan H (2025). [PMID: 40907058](https://pubmed.ncbi.nlm.nih.gov/40907058/). *Neuromuscular disorders : NMD*. [Epidemiology / Natural History]
Li J (2025). [PMID: 40200352](https://pubmed.ncbi.nlm.nih.gov/40200352/). *Orphanet journal of rare diseases*. [Epidemiology / Natural History]
Kediha MI (2025). [PMID: 39379219](https://pubmed.ncbi.nlm.nih.gov/39379219/). *Revue neurologique*. [Basic Science / Preclinical]
Zhang J (2025). [PMID: 40442802](https://pubmed.ncbi.nlm.nih.gov/40442802/). *Orphanet journal of rare diseases*. [Epidemiology / Natural History]
Inan B (2025). [PMID: 41059415](https://pubmed.ncbi.nlm.nih.gov/41059415/). *Northern clinics of Istanbul*. [Epidemiology / Natural History]
Kurtovic-Kozaric A (2024). [PMID: 39720176](https://pubmed.ncbi.nlm.nih.gov/39720176/). *Frontiers in genetics*. [Diagnostic / Biomarker]